Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
Clinical trial NCT01902251 · COMPLETED
Trial details
- NCT number
- NCT01902251
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.